Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP501029.RApxd1vfirJ_j8SP3jHi_JGIyfuBro2f9foZjKZO2fGN8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP501029.RApxd1vfirJ_j8SP3jHi_JGIyfuBro2f9foZjKZO2fGN8130_assertion type Assertion NP501029.RApxd1vfirJ_j8SP3jHi_JGIyfuBro2f9foZjKZO2fGN8130_head.
- NP501029.RApxd1vfirJ_j8SP3jHi_JGIyfuBro2f9foZjKZO2fGN8130_assertion description "[Three important characteristics of alveolar soft part sarcoma, the presence of ASPSCR1-TFE3 fusion transcript, nuclear immunoreactivity for TFE3, and immunoreactivity for monocarboxylate transporter 1 and CD147, have recently been reported.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501029.RApxd1vfirJ_j8SP3jHi_JGIyfuBro2f9foZjKZO2fGN8130_provenance.
- NP501029.RApxd1vfirJ_j8SP3jHi_JGIyfuBro2f9foZjKZO2fGN8130_assertion evidence source_evidence_literature NP501029.RApxd1vfirJ_j8SP3jHi_JGIyfuBro2f9foZjKZO2fGN8130_provenance.
- NP501029.RApxd1vfirJ_j8SP3jHi_JGIyfuBro2f9foZjKZO2fGN8130_assertion SIO_000772 21835426 NP501029.RApxd1vfirJ_j8SP3jHi_JGIyfuBro2f9foZjKZO2fGN8130_provenance.
- NP501029.RApxd1vfirJ_j8SP3jHi_JGIyfuBro2f9foZjKZO2fGN8130_assertion wasDerivedFrom befree-20140225 NP501029.RApxd1vfirJ_j8SP3jHi_JGIyfuBro2f9foZjKZO2fGN8130_provenance.
- NP501029.RApxd1vfirJ_j8SP3jHi_JGIyfuBro2f9foZjKZO2fGN8130_assertion wasGeneratedBy ECO_0000203 NP501029.RApxd1vfirJ_j8SP3jHi_JGIyfuBro2f9foZjKZO2fGN8130_provenance.